Guided Therapeutics (GTHP) Change in Cash (2016 - 2025)
Guided Therapeutics' Change in Cash history spans 15 years, with the latest figure at -$24000.0 for Q4 2025.
- On a quarterly basis, Change in Cash fell 112.37% to -$24000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$325000.0, a 60.1% decrease, with the full-year FY2025 number at -$325000.0, down 60.1% from a year prior.
- Change in Cash hit -$24000.0 in Q4 2025 for Guided Therapeutics, up from -$98000.0 in the prior quarter.
- Over the last five years, Change in Cash for GTHP hit a ceiling of $2.3 million in Q3 2022 and a floor of -$627000.0 in Q3 2023.
- Historically, Change in Cash has averaged -$5950.0 across 5 years, with a median of -$143000.0 in 2023.
- Biggest five-year swings in Change in Cash: skyrocketed 690.81% in 2022 and later tumbled 680.49% in 2023.
- Tracing GTHP's Change in Cash over 5 years: stood at $102000.0 in 2021, then crashed by 476.47% to -$384000.0 in 2022, then soared by 63.54% to -$140000.0 in 2023, then soared by 238.57% to $194000.0 in 2024, then plummeted by 112.37% to -$24000.0 in 2025.
- Business Quant data shows Change in Cash for GTHP at -$24000.0 in Q4 2025, -$98000.0 in Q3 2025, and $70000.0 in Q2 2025.